Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Title:
Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Author:
Schreiber, Stefan Feagan, Brian D’Haens, Geert Colombel, Jean–Frederic Geboes, Karel Yurcov, Mikhail Isakov, Vasily Golovenko, Oleg Bernstein, Charles N. Ludwig, Diether Winter, Trevor Meier, Ulrich Yong, Chan Steffgen, Jürgen
Appeared in:
Clinical gastroenterology and hepatology
Paging:
Volume 4 (2006) nr. 3 pages 10 p.
Year:
2006
Contents:
Publisher:
American Gastroenterological Association Institute